Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Business Models and Strategy

 

Interview: Jose Bailey, commercial director, CHEC

UK-based and NHS focused ophthalmology group CHEC is branching out - expanding its offering, going private in Wales, and diversifying into endoscopy with new dual purpose clinics. HBI chats with Jose Bailey, commercial director, to find out more.

The secret to REIT success: Be picky

As inflation and energy costs spiral out of control, traditional brick and mortar investments in elderly care are increasingly being perceived as potentially risky business. An award-winning Madrid-based REIT tells HBI its formula success in a difficult climate.

Orpea shareholders try to avoid mass dilution

French nursing home giant Orpea’s snubbed shareholders group Concert’O has teamed up with other unsecured lenders in a last-ditch attempt to avoid mass share dilution. Protesting at the operator’s restructuring deal, the group has presented an alternative plan. 

Bupa Dental Care to close 85 UK practices

Bupa Dental Care, the UK’s second largest dentistry group by revenue, is closing 85 of its 450 UK practices. The group says the move was driven by difficulty in recruiting enough dentists to provide NHS care, as well as rising costs and difficulties surrounding the NHS contract model.

Ultrasound the ‘biggest opportunity in UK imaging’

Ultrasound represents the biggest opportunity in diagnostic imaging in the UK market, according to a major operator in the sector. Portability, lower costs and larger volumes compared to X-ray, CT and MRI make it particularly attractive for agile for-profit providers in a sector long-dominated by the NHS.

Interview: Sam Gray, Apposite Capital

London-based PE group Apposite Capital is among the most active investors in health care in Europe. HBI chats with managing partner Sam Gray about the state of the market and pricing, how he sees that changing, and the investment opportunities piquing his interest at present.

Could Orpea’s creditors derail a ‘done deal’?

Orpea is trying to put a year of scandal, scrutiny, and scathing headlines behind it, but disgrunteld creditors worried about share dilution are attempting to derail its carefully crafted transformational plan. HBI speaks to a market expert to weigh up their prospects for success, and find out more.

Japanese investors target African health care

An increasing number of Japanese investors are looking to invest in African health care. As Africa strives to increase accessibility to care and increase insurance coverage, we speak to an investor who things the Japanese model is a good fit.

Find Us